ALLIANCE A031902

Primary Category:

Treatment Protocols

Disease Category:

Genitourinary, Prostate Metastatic

Status:

Temporarily Closed

CASPAR – A Phase III Trial of Enzalutamide and Rucaparib as a Novel Therapy in First-Line Metastatic Castration-Resistant Prostate Cancer

Eligible for screening study DCP 001

A031902 is temporarily suspended to new patient registration (OPEN Step 0), effective  April 10, 2023.

A031902 is temporarily suspended to new patient registration (OPEN Step 2), effective  May 10, 2023.

NCT#04455750